McMurry-Heath: COVID-19 raises stakes for industry to take the lead on promoting science: a BioCentury audio interview

Michelle McMurry-Heath, three months into her role as president and CEO of BIO, sees the pandemic as a crucial time for the biopharma industry to tell its story better to the public, and ensure its foundation of science is both understood and used to benefit all everyone.

In a Back to School interview, McMurry-Heath discussed the lessons she thinks the industry can learn from its response to COVID-19. The conversation was one in a series of interviews with industry leaders for BioCentury’s Back to School 2020 package (see Cover Story: “The Imperative of COVID-19”)...